CDKN2B and neoplasm: Compound knockout of Cdkn2a and Cdkn2b (deficient for p15INK4b, p16INK4a and p19ARF) or Cdkn2a and Tp53 in mice did increase tumor predisposition in general, but did not promote melanoma development 20, 24.